MHC
SLXN

Meyer Handelman Company’s Silexion Therapeutics Corp Ordinary Shares SLXN Stock Holding History

Meyer Handelman Company’s Portfolio SLXN Stock Details SLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$26.7K Hold
2,198
– – ﹤0.01% 216
2025
Q1 		$36.3K Buy
+2,198
New +$36.3K ﹤0.01% 213